Solid Biosciences
SLDB
SLDB
75 hedge funds and large institutions have $648M invested in Solid Biosciences in 2018 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 28 increasing their positions, 16 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 76 → 75 (-1)
26% less capital invested
Capital invested by funds: $878M → $648M (-$229M)
40% less call options, than puts
Call options by funds: $3.88M | Put options by funds: $6.44M
Holders
75
Holding in Top 10
5
Calls
$3.88M
Puts
$6.44M
Top Buyers
| 1 | +$105M | |
| 2 | +$23.2M | |
| 3 | +$21.1M | |
| 4 |
BC
Boxer Capital
San Diego,
California
|
+$16.5M |
| 5 |
State Street
Boston,
Massachusetts
|
+$14.5M |
Top Sellers
| 1 | -$34.6M | |
| 2 | -$18.9M | |
| 3 | -$13.9M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$6.61M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$4.64M |